Annual CFO:
-$181.39M-$30.28M(-20.04%)Summary
- As of today, XENE annual cash from operations is -$181.39 million, with the most recent change of -$30.28 million (-20.04%) on December 31, 2024.
- During the last 3 years, XENE annual cash from operations has fallen by -$111.89 million (-160.98%).
- XENE annual cash from operations is now -498.02% below its all-time high of $45.57 million, reached on December 31, 2012.
Performance
XENE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$66.53M-$4.88M(-7.91%)Summary
- As of today, XENE quarterly cash from operations is -$66.53 million, with the most recent change of -$4.88 million (-7.91%) on June 1, 2025.
- Over the past year, XENE quarterly cash from operations has dropped by -$35.93 million (-117.39%).
- XENE quarterly cash from operations is now -434.41% below its all-time high of $19.90 million, reached on December 31, 2019.
Performance
XENE Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$230.56M-$35.93M(-18.46%)Summary
- As of today, XENE TTM cash from operations is -$230.56 million, with the most recent change of -$35.93 million (-18.46%) on June 1, 2025.
- Over the past year, XENE TTM cash from operations has dropped by -$77.62 million (-50.76%).
- XENE TTM cash from operations is now -7249.73% below its all-time high of $3.22 million, reached on September 30, 2014.
Performance
XENE TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
XENE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -20.0% | -117.4% | -50.8% |
| 3Y3 Years | -161.0% | -297.8% | -229.5% |
| 5Y5 Years | -3747.9% | -537.2% | -1379.1% |
XENE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -161.0% | at low | -126.4% | at low | -171.0% | at low |
| 5Y | 5-Year | -3747.9% | at low | -455.6% | at low | -1379.1% | at low |
| All-Time | All-Time | -498.0% | at low | -434.4% | at low | -7249.7% | at low |
XENE Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$66.53M(-7.9%) | -$230.56M(-18.5%) |
| Mar 2025 | - | -$61.65M(-20.4%) | -$194.63M(-8.6%) |
| Dec 2024 | -$181.39M(-20.0%) | -$51.19M(+0.0%) | -$179.17M(-10.8%) |
| Sep 2024 | - | -$51.19M(-67.3%) | -$161.67M(-5.7%) |
| Jun 2024 | - | -$30.60M(+33.7%) | -$152.93M(+1.8%) |
| Mar 2024 | - | -$46.19M(-37.1%) | -$155.79M(-8.2%) |
| Dec 2023 | -$151.11M(-49.6%) | -$33.69M(+20.6%) | -$144.01M(-2.7%) |
| Sep 2023 | - | -$42.45M(-26.9%) | -$140.18M(-10.3%) |
| Jun 2023 | - | -$33.46M(+2.8%) | -$127.10M(-15.2%) |
| Mar 2023 | - | -$34.41M(-15.3%) | -$110.37M(-16.9%) |
| Dec 2022 | -$101.03M(-45.4%) | -$29.85M(-1.6%) | -$94.39M(-10.9%) |
| Sep 2022 | - | -$29.38M(-75.7%) | -$85.08M(-21.6%) |
| Jun 2022 | - | -$16.73M(+9.2%) | -$69.97M(-4.7%) |
| Mar 2022 | - | -$18.43M(+10.3%) | -$66.84M(+3.3%) |
| Dec 2021 | -$69.50M(-44.4%) | -$20.55M(-44.1%) | -$69.12M(-10.4%) |
| Sep 2021 | - | -$14.26M(-4.9%) | -$62.63M(-3.8%) |
| Jun 2021 | - | -$13.60M(+34.3%) | -$60.34M(-5.5%) |
| Mar 2021 | - | -$20.71M(-47.4%) | -$57.18M(-15.4%) |
| Dec 2020 | -$48.12M(-920.9%) | -$14.05M(-17.4%) | -$49.54M(-217.8%) |
| Sep 2020 | - | -$11.97M(-14.7%) | -$15.59M(-42.8%) |
| Jun 2020 | - | -$10.44M(+20.1%) | -$10.92M(-20.6%) |
| Mar 2020 | - | -$13.07M(-165.7%) | -$9.06M(-94.5%) |
| Dec 2019 | -$4.71M | $19.90M(+372.3%) | -$4.66M(+85.3%) |
| Sep 2019 | - | -$7.31M(+14.8%) | -$31.57M(+16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$8.58M(+1.0%) | -$37.71M(-9.2%) |
| Mar 2019 | - | -$8.67M(-23.4%) | -$34.53M(-1.3%) |
| Dec 2018 | -$34.72M(-20.9%) | -$7.02M(+47.8%) | -$34.08M(-1.7%) |
| Sep 2018 | - | -$13.44M(-148.9%) | -$33.52M(-12.5%) |
| Jun 2018 | - | -$5.40M(+34.3%) | -$29.79M(+4.2%) |
| Mar 2018 | - | -$8.22M(-27.2%) | -$31.09M(-6.0%) |
| Dec 2017 | -$28.73M(-46.8%) | -$6.46M(+33.5%) | -$29.33M(-8.1%) |
| Sep 2017 | - | -$9.71M(-45.0%) | -$27.14M(-24.1%) |
| Jun 2017 | - | -$6.70M(-3.7%) | -$21.88M(-4.5%) |
| Mar 2017 | - | -$6.46M(-51.1%) | -$20.94M(-7.8%) |
| Dec 2016 | -$19.57M(-8.1%) | -$4.28M(+3.8%) | -$19.43M(+3.9%) |
| Sep 2016 | - | -$4.45M(+22.9%) | -$20.22M(-0.9%) |
| Jun 2016 | - | -$5.76M(-16.6%) | -$20.05M(-19.7%) |
| Mar 2016 | - | -$4.94M(+2.4%) | -$16.74M(+3.5%) |
| Dec 2015 | -$18.10M(-6905.6%) | -$5.07M(-18.7%) | -$17.34M(-13.8%) |
| Sep 2015 | - | -$4.27M(-73.5%) | -$15.24M(-225.6%) |
| Jun 2015 | - | -$2.46M(+55.6%) | -$4.68M(-5.3%) |
| Mar 2015 | - | -$5.55M(-87.0%) | -$4.45M(-1819.4%) |
| Dec 2014 | $266.00K(+108.0%) | -$2.97M(-147.1%) | $258.60K(-92.0%) |
| Sep 2014 | - | $6.29M(+382.8%) | $3.22M(+205.1%) |
| Jun 2014 | - | -$2.23M(-164.3%) | -$3.07M(-264.3%) |
| Mar 2014 | - | -$842.00K | -$842.00K |
| Dec 2013 | -$3.32M(-107.3%) | - | - |
| Dec 2012 | $45.57M(+432.9%) | - | - |
| Dec 2011 | -$13.69M | - | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual cash from operations year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly cash from operations year-on-year change?
- What is Xenon Pharmaceuticals Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. TTM cash from operations year-on-year change?
What is Xenon Pharmaceuticals Inc. annual cash from operations?
The current annual cash from operations of XENE is -$181.39M
What is the all-time high annual cash from operations for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual cash from operations is $45.57M
What is Xenon Pharmaceuticals Inc. annual cash from operations year-on-year change?
Over the past year, XENE annual cash from operations has changed by -$30.28M (-20.04%)
What is Xenon Pharmaceuticals Inc. quarterly cash from operations?
The current quarterly cash from operations of XENE is -$66.53M
What is the all-time high quarterly cash from operations for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly cash from operations is $19.90M
What is Xenon Pharmaceuticals Inc. quarterly cash from operations year-on-year change?
Over the past year, XENE quarterly cash from operations has changed by -$35.93M (-117.39%)
What is Xenon Pharmaceuticals Inc. TTM cash from operations?
The current TTM cash from operations of XENE is -$230.56M
What is the all-time high TTM cash from operations for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high TTM cash from operations is $3.22M
What is Xenon Pharmaceuticals Inc. TTM cash from operations year-on-year change?
Over the past year, XENE TTM cash from operations has changed by -$77.62M (-50.76%)